IRISYS Awarded $850,000 NIH Contract for the Formulation of Drinabant, a Drug in Development for Treatment of Acute Cannabinoid Overdose

CANNANNEW REPORT

IRISYS, LLC, a San Diego-based provider of contract pharmaceutical product development and manufacturing services, today announced that it was awarded… Read More….. The post IRISYS Awarded $850,000 NIH Contract for the Formulation of Drinabant, a Drug in Development for Treatment of Acute Cannabinoid Overdose first appeared on Cannabis Law Report.

Excerpt only …
READ MORE BELOW
Source : IRISYS Awarded 0,000 NIH Contract for the Formulation of Drinabant, a Drug in Development for Treatment of Acute Cannabinoid Overdose

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.